Autres langues Patrys Limited

Actions

PAB

AU000000PAB9

Marché Fermé - Australian S.E. Autres places de cotation 07:05:00 03/05/2024			Varia. 5j.	Varia. 1 janv.
0,008 ^AUD	0,00%		-11,11%	0,00%

23/02	Patrys Limited annonce ses résultats pour le semestre clos le 31 décembre 2023	CI
2023	Patrys commencera la production de PAT-DX1 au premier trimestre 2024	MT

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Patrys Reports 'Positive' Results for Deoxymabs in Autoimmune Vasculitis Treatment	10/04
Patrys Limited Reports Earnings Results for the Half Year Ended December 31, 2023	23/02
Patrys to Begin Production of PAT-DX1 in Q1 2024	13/12
Patrys Limited Announces Retirement of Suzy Jones as Director	14/09/23
Patrys Limited Reports Earnings Results for the Full Year Ended June 30, 2023	28/08/23
Patrys Reports 'Favorable' Results from Pre-Clinical Study of Cancer Therapy	24/05/23
US Patent Office Grants Patrys Two New Deoxymab Patents	18/04/23
Patrys secures US patents for antibody technology	17/04/23
Patrys Moves Phase One Trial for Brain Cancer Drug to 2024; Shares Tumble 24%	31/03/23
Patrys Limited Announces New PAT-DX3 Data Demonstrates Synthetic Lethality	13/03/23
Patrys Limited Reports Earnings Results for the Half Year Ended December 31, 2022	24/02/23
Patrys Unit Secures AU$3 Million R&D Tax Refund	30/01/23
Patrys : Insights Care Magazine \| Interview with Dr James Campbell	30/11/22
Patrys Appoints Global Biotechnology Leader as Chairman - In Preparation for First Clinical Trial for Groundbreaking Cancer Therapy	18/11/22
Patrys Names Chairman	16/11/22
Patrys Limited Appoints Charmaine Gittleson as the Chairman of the Board of Directors, Effective November 16, 2022	15/11/22
Patrys : INTERVIEW \| Dr James Campbell on Proactive	17/10/22
Patrys Limited Announces New Preclinical Data for its Full-Sized IgG Antibody, Pat-DX3	16/10/22
Patrys Limited Announces Appointment of Mr. Stefan Ross as Non-Executive Director	31/08/22
Patrys Limited Reports Earnings Results for the Full Year Ended June 30, 2022	30/08/22

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Patrys Limited

Actions

PAB

AU000000PAB9

Autres langues

Filtres